Indications for Use
Description of the disease or condition the device will diagnose, treat, prevent, cure, or mitigate.
Definition
The Indications for Use statement is a specific statement of disease, condition, or anatomical site for which a device is intended, including the patient population.What this means in practice
Indications for Use is a specific, regulatorily significant subset of intended use, captured in 510(k) and PMA decision summaries.Examples
- A continuous glucose monitor's Indications for Use state: "For use by people age 18 years and older with diabetes mellitus for the management of their diabetes through the measurement of glucose levels in interstitial fluid."
- A surgical robot's Indications for Use specifies: "Intended for use in general laparoscopic surgical procedures to assist in the precise manipulation of instruments and visualization of the surgical field."
- An in vitro diagnostic test's Indications for Use might declare: "For the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen from nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset."
- •Confusing "Indications for Use" with "intended use" can lead to mislabeling and regulatory non-compliance.
- •Failing to precisely define the patient population or conditions can result in a device being used off-label, creating safety risks.
- •Inconsistent Indications for Use across different official documents, such as regulatory submissions and marketing materials, can trigger regulatory scrutiny.
- •Not clearly delineating the specific disease or condition the device addresses can lead to ambiguity in its application and efficacy claims.
- •Omitting contraindications or warnings within the labeling related to the Indications for Use can result in adverse events and regulatory actions.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsThe objective intent of the manufacturer regarding the use of the device.
FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
FDA's most stringent device marketing application, required for high-risk Class III devices.
510(k) Fundamentals
· From this learning pathA legally marketed device used as the comparator in a 510(k) submission.
Pathway to classify novel low- to moderate-risk devices that lack a predicate.
The legal standard a 510(k) device must meet versus a predicate.
FDA administrative decision that a submission is incomplete and won't be substantively reviewed.
De Novo & Breakthrough Pathways
· From this learning pathFDA program providing expedited review for devices that treat life-threatening or irreversibly debilitating conditions.
Product comprised of two or more regulated components - e.g., drug-device, biologic-device.
Voluntary mechanism to obtain FDA feedback before a formal premarket submission.
Formal FDA feedback request prior to a marketing or IDE submission.
Primary references
3 sources- 1
European Commission - Medical DevicesVerifiedEuropean Commissionhealth.ec.europa.eu
- 2
IMDRF DocumentsVerifiedIMDRFimdrf.org
- 3
RAPS Regulatory FocusVerifiedRAPSraps.org
Inline markers like [1] jump to the matching reference above.